Gemini Therapeutics

Developer of precision therapeutics for dry AMD and rare genetic diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups45 employees language geminitherapeutics.com

Registered entities

Innovation

11 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 53 times.

YearFilings
20181
20192
20207
20217
20221

Investor mix

4 investors on record; lead investors include Atlas Venture, Lightstone Ventures, Orbimed.

Investor typeCountShare
Venture capital4100%
Coming soon